Class: Dual GIP + GLP-1 Receptor Agonist with Niacinamide Support

• How it works: Tirzepatide activates both GLP-1 and GIP receptors to reduce appetite, regulate blood sugar, and support fat metabolism.

• Dosing and mechanism: Same as tirzepatide (see above), approved specifically for obesity treatment

• Typical dosing:

  • Start: 2.5 mg weekly

  • Increase every 4 weeks to 5 mg, 10 mg, or 15 mg as tolerated